Qingyang Lei

1.2k total citations · 2 hit papers
15 papers, 852 citations indexed

About

Qingyang Lei is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Qingyang Lei has authored 15 papers receiving a total of 852 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Qingyang Lei's work include Immune Cell Function and Interaction (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Immune cells in cancer (4 papers). Qingyang Lei is often cited by papers focused on Immune Cell Function and Interaction (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Immune cells in cancer (4 papers). Qingyang Lei collaborates with scholars based in China, United States and Philippines. Qingyang Lei's co-authors include Yi Zhang, Liping Wang, Kai Sun, Dan Wang, Yi Zhang, Aitian Li, Li Yang, Weina Yu, Li Yang and Dan Wang and has published in prestigious journals such as International Journal of Cancer, Frontiers in Immunology and Advanced Science.

In The Last Decade

Qingyang Lei

13 papers receiving 842 citations

Hit Papers

Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid T... 2020 2026 2022 2024 2020 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingyang Lei China 8 441 392 333 225 143 15 852
Zachary Rae United States 5 381 0.9× 371 0.9× 346 1.0× 231 1.0× 125 0.9× 7 806
Anliang Xia China 12 469 1.1× 379 1.0× 455 1.4× 260 1.2× 106 0.7× 18 960
Balaji Virassamy Australia 10 652 1.5× 360 0.9× 231 0.7× 174 0.8× 246 1.7× 12 946
Sayali Onkar United States 8 539 1.2× 497 1.3× 382 1.1× 208 0.9× 149 1.0× 11 989
Qitai Zhao China 13 310 0.7× 334 0.9× 249 0.7× 152 0.7× 95 0.7× 31 650
Ruoyu Ma China 8 360 0.8× 372 0.9× 345 1.0× 130 0.6× 82 0.6× 10 809
Sofia Sousa France 10 399 0.9× 355 0.9× 326 1.0× 138 0.6× 132 0.9× 15 843
Yuze Hua China 6 301 0.7× 211 0.5× 317 1.0× 216 1.0× 125 0.9× 14 670

Countries citing papers authored by Qingyang Lei

Since Specialization
Citations

This map shows the geographic impact of Qingyang Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingyang Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingyang Lei more than expected).

Fields of papers citing papers by Qingyang Lei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingyang Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingyang Lei. The network helps show where Qingyang Lei may publish in the future.

Co-authorship network of co-authors of Qingyang Lei

This figure shows the co-authorship network connecting the top 25 collaborators of Qingyang Lei. A scholar is included among the top collaborators of Qingyang Lei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingyang Lei. Qingyang Lei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Wang, Yunhan, Weina Yu, Xinxin Wang, et al.. (2025). TREM2‐Mediated Cholesterol Efflux in Macrophages Inhibits Anti‐Tumor Immunity via Limitation of CD4 + T and NK Cells. Advanced Science. 13(5). e06995–e06995. 1 indexed citations
2.
Lei, Qingyang, Yang Li, Weina Yu, et al.. (2025). Tumor Exosomal HIF2A Induce Peritumoral M2 Macrophages Accumulation to Facilitate Intestinal Invasion in Colorectal Cancer. Theranostics. 15(15). 7709–7725.
3.
Wang, Ying, Wei Yin, Qingyang Lei, et al.. (2025). Identification and validation of prognostic genes and prognostic models associated with cutaneous melanoma and integrative stress response. Frontiers in Immunology. 16. 1689103–1689103.
4.
Lei, Qingyang, et al.. (2024). A2AR-mediated CXCL5 upregulation on macrophages promotes NSCLC progression via NETosis. Cancer Immunology Immunotherapy. 73(6). 108–108. 12 indexed citations
5.
Li, Yang, Aitian Li, Dan Wang, et al.. (2024). Blockade of purine metabolism reverses macrophage immunosuppression and enhances anti-tumor immunity in non-small cell lung cancer. Drug Resistance Updates. 78. 101175–101175. 14 indexed citations
6.
Wang, Dan, Yu-Jie Xu, Jinbo Liu, et al.. (2023). IL8 derived from macrophages inhibits CD8+ T-cell function by downregulating TIM3 expression through IL8-CXCR2 axis in patients with advanced colorectal cancer. International Immunopharmacology. 121. 110457–110457. 3 indexed citations
8.
Yu, Weina, et al.. (2022). Identification of Key Pathways and Genes Related to Immunotherapy Resistance of LUAD Based on WGCNA Analysis. Frontiers in Oncology. 11. 814014–814014. 9 indexed citations
9.
Liu, Yanfen, Zhen Zhang, Yonggui Tian, et al.. (2022). Long-term clinical efficacy of cytokine-induced killer cell-based immunotherapy in early-stage esophageal squamous cell carcinoma. Cytotherapy. 24(5). 526–533. 3 indexed citations
10.
Shen, Chunyi, et al.. (2022). Mechanism and strategies of immunotherapy resistance in colorectal cancer. Frontiers in Immunology. 13. 1016646–1016646. 38 indexed citations
11.
Qu, Jiao, Qitai Zhao, Li Yang, et al.. (2021). Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma. International Immunopharmacology. 96. 107616–107616. 6 indexed citations
12.
Yu, Weina, Qingyang Lei, Li Yang, et al.. (2021). Contradictory roles of lipid metabolism in immune response within the tumor microenvironment. Journal of Hematology & Oncology. 14(1). 187–187. 170 indexed citations breakdown →
13.
Lei, Qingyang, Dan Wang, Kai Sun, Liping Wang, & Yi Zhang. (2020). Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors. Frontiers in Cell and Developmental Biology. 8. 672–672. 297 indexed citations breakdown →
14.
Li, Yang, Ying Dong, Yanjun Li, et al.. (2019). IL‐10 derived from M2 macrophage promotes cancer stemness via JAK1/STAT1/NF‐κB/Notch1 pathway in non‐small cell lung cancer. International Journal of Cancer. 145(4). 1099–1110. 142 indexed citations
15.
Yang, Li, Aitian Li, Qingyang Lei, & Yi Zhang. (2019). Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment. Journal of Hematology & Oncology. 12(1). 125–125. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026